Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Praxis Precision Medicines

Request full access

Developing therapies for central nervous system disorders based on genetic insights into neuronal imbalance

Cambridge, United StatesFounded 2015Biotech & Life Sciences

About Praxis Precision Medicines

Praxis Precision Medicines is a clinical stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, particularly those characterized by neuronal imbalance. The company leverages insights from genetic epilepsies to create innovative treatments aimed at addressing unmet medical needs. Praxis operates in the biopharmaceutical market, primarily serving patients with CNS disorders and their caregivers. The business model revolves around patient-guided development strategies, ensuring that the therapies developed are aligned with what patients actually need. Revenue is generated through the development and potential commercialization of these therapies, as well as through partnerships and collaborations with other entities in the healthcare sector.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Praxis Precision Medicines in the Cambridge ecosystem

Live from Dealroom

The Praxis Precision Medicines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later14 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$36M

49 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Praxis Precision Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.